Anthony Warnock-Smith

Firm(s):

Morgan, Lewis & Bockius LLP

Email:

Articles:

Why The European Union? - Regulatory Issues Surrounding Medicinal Products - Part II

Thursday, February 1, 2007

Part I of this article appearing on page 44 of the January issue of The Metropolitan Corporate Counsel described the regulatory regime in the EU for companies wishing to conduct clinical trials. Obtaining A Marketing Authorization A. General Requirements
Why The European Union? - Regulatory Issues Surrounding Medicinal Products - Part I

Monday, January 1, 2007

Part II of this article apperas in the February 2007 issue of The Metropolitan Corporate Counsel. For businesses in any industry, the European Union (EU) is a market force to be reckoned with. Currently made up of 25 Member States, the EU is the world's largest economy by gross domestic product, and it is the third largest population. Its reach and market...